Health News Releases

  • Today February 19
March 03, 2014 16:50
On the Day World Recognizes 350m Rare Disease Sufferers, Quintiles Publishes Insights in Tackling the Challenges
Marking today’s commemoration of ‘World Rare Disease Day’, Quintiles (www.quintiles.com)points to the 350 million people around the globe suffering from rare diseases - gathered together they would be
March 03, 2014 16:05
Mapi Appoints Dr. Terri Madison Vice President, Epidemiology & Risk Management, North America
Mapi, the leading expert in Observational Studies, Health Economics and Real-World Evidence, announces the appointment of Dr. Terri Madison as Vice President, Epidemiology & Risk Management, North Ame
March 03, 2014 13:30
ASTHMA: New Phase III data show tiotropium* Respimat® effective across asthma severities
For Media outside the U.S., Canada and UK Boehringer Ingelheim today announced new data from large scale, Phase III studies showing that once-daily tiotropium delivered via the Respimat® inhaler wa
Beltone First is a Made for iPhone hearing aid that offers direct streaming of sound from iPhone, iP
February 28, 2014 16:25
Beltone Launches Beltone First, a Revolutionary Hearing Aid
Beltone First™ hits the market today as a revolutionary hearing aid capable of streaming high-quality stereo sound from an iPhone®, iPad® and iPod touch® without the need for an additional pendant-lik
February 28, 2014 11:53
Cell Therapy: Technologies, Markets and Companies-A 2014 Report With 292 Companies Involved in Cell Therapy Profiled
Research and Markets (http://www.researchandmarkets.com/research/m5svn5/cell_therapy) has announced the addition of a new report “Cell Therapy - Technologies, Markets and Companies” to their offering.
PillCam SB is the most widely used, patient-friendly tool for directly visualizing the small bowel t
February 27, 2014 21:00
Covidien Completes Acquisition of Given Imaging
Covidien plc (NYSE: COV) today announced that it has closed its acquisition of Given Imaging Ltd., providing the company additional scale and scope to serve a significant medical specialty, the multib
February 27, 2014 12:02
The Healthcare Analytics/Medical Analytics Market Report, Segmented by Application, Type, End-user, Delivery Mode, and Geography
Research and Markets(http://www.researchandmarkets.com/research/x28xs7/healthcare) has announced the addition of the “Healthcare Analytics/Medical Analytics Market by Application, Type, End-user, Deli
February 27, 2014 11:39
The Molecular Diagnostics Market: An In-Depth Analysis of the Main Global Markets With Over 50 Company Profiles Included
Research and Markets(http://www.researchandmarkets.com/research/93trzd/molecular) has announced the addition of the “Molecular Diagnostics Markets(http://www.researchandmarkets.com/research/93trzd/mol
February 26, 2014 14:00
Pathway Genomics Acquires FDA-Cleared Illumina MiSeqDx Next-Generation Sequencing Systems
Pathway Genomics Corporation (www.pathway.com), a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services worldwide, today announced it has added the Illumina
February 26, 2014 11:46
Neuroprotection-An In-Depth Report Covering Key Topics Including Drugs, Markets and Companies
Research and Markets (http://www.researchandmarkets.com/research/hhg7xg/neuroprotection) has announced the addition of a new report “Neuroprotection - Drugs, Markets and Companies(http://www.researcha
Hisao Tanaka, President and CEO, Toshiba Corporation
February 25, 2014 22:20
Toshiba Introduces New Healthcare Business Strategy
Toshiba Corporation (TOKYO:6502) has introduced the strategy that it will promote to establish its healthcare business as a third main pillar of operations, along with its energy and storage businesse
February 25, 2014 20:50
SCYNEXIS Receives Qualified Infectious Disease Product (QIDP) Designation from the FDA for Antifungal Agent SCY-078 for Oral Use
Drug discovery and development company SCYNEXIS, Inc., today announced that the Food and Drug Administration (FDA) designated SCY-078 as a Qualified Infectious Disease Product (QIDP) for oral use for
February 25, 2014 20:00
WIN Consortium Appoints Winston and Strawn LLP as Official Legal Counsel
The Worldwide Innovative Network (WIN) Consortium in personalized cancer medicine, www.winconsortium.org is proud to announce Winston and Strawn LLP (www.winston.com) has been appointed as their offic
ReSound LiNX is a revolutionary hearing aid capable of streaming high-quality stereo sound from an i
February 25, 2014 17:25
GN ReSound® Launches ReSound LiNX™, a Revolutionary Hearing Aid
ReSound LiNX launches in global markets today as a revolutionary hearing aid capable of streaming high-quality stereo sound from an iPhone®, iPad® and iPod touch® without the need for an additional pe
February 21, 2014 13:55
Mapi Chief Medical Officer, Ronald Christensen, M.D., to Speak at Orphan Drug Conferences on Implementation of Patient Registries in Orphan Drug Development
Mapi, the leading expert in Observational Studies, Health Economics and Outcomes Research (HEOR) and Real-World Evidence, announces that Ronald Christensen, M.D., Chief Medical Officer at Mapi and an
February 20, 2014 23:00
Wolters Kluwer Health Announces Global Launch of UpToDate Anywhere, mHealth Decision Support Resource
Wolters Kluwer Health (www.wolterskluwerhealth.com), a leading global provider of information for healthcare professionals and students, announced today the global launch of UpToDate® Anywhere, enabli
February 19, 2014 14:50
Pathway Genomics Launches Hereditary Colorectal Cancer Genetic Test
Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services worldwide, today announced the launch of Hereditary Colorectal Cancer D
February 19, 2014 11:20
IntegenX Launches New GlobalFiler(R) Express Cartridges for RapidHIT(TM) System at the American Academy of Forensic Sciences (AAFS) Meeting
IntegenX Inc.(http://integenx.com/), the market leader in Rapid Human DNA identification technology, today announced the launch of GlobalFiler® Express cartridges for the RapidHIT™ System, providing D
February 19, 2014 11:00
STC Life Co., Ltd. Successfully Treats Patients With Parkinson's Disease at Stem Cell Research and Treatment Center
Stem cell research institute (http://goo.gl/RCJcFS) of STC Life Co., Ltd. (Chairman: KYE HO LEE, http://goo.gl/1P02lk) and 97.7 B&H Clinic (Director: WON JU JUNG) successfully completed mesenchymal st
February 18, 2014 17:00
Acerde Signs a Development Contract with a China-based Leader in Medical Imaging
Acerde, an innovative company specializing in the development of rotating anodes for X-ray tubes used in the medical imaging industry, today announced (i) the signature of a development contract with
February 17, 2014 16:40
Moberg Pharma and Menarini Extend Distribution Agreement for Kerasal Nail to South East Asia
Moberg Pharma AB (OMX: MOB) and Menarini Asia-Pacific, a member of the Menarini Group are pleased to announce that Menarini Asia-Pacific has been granted the exclusive rights to market and sell Kerasa
February 12, 2014 11:00
Nestlé Skin Health Is Created Targeting Global Skin Health Needs
Today, Nestlé S.A. (Nestlé) announced the creation of Nestlé Skin Health S.A., a global leader focused on meeting the world’s increasing skin health needs with a scientifically-proven broad range of i
February 10, 2014 20:00
SuperECG: Mobile 24H ECG with Samsung G S4 - Analyze Your Heart Rhythm with Your Phone
SuperECG.com has tested its 24 h ECG analysis service with Samsung smartphones. “It is now possible to do a proper 24 h ECG heart rhythm monitoring with a smartphone. We tested our HeartBug servic
Adjusted EBITDA
February 07, 2014 12:00
22nd Century Group Files Annual Report and Provides Business Update
22nd Century Group, Inc. (OTCQB:XXII, http://goo.gl/7CavNZ) today announced that the Company filed its 2013 report on Form 10-K with the Securities and Exchange Commission. For year ended December
February 07, 2014 10:10
New Paper Indicates a Potential Fifty-Percent Reduction in Cardiac Events for Prostate Cancer Patients with Pre-Existing Cardiovascular Disease When Treated With FIRMAGON® (degarelix) Compared To LHRH Agonists
A paper published today in European Urology, the official journal of the European Association of Urology, indicates that the gonadotropin releasing hormone (GnRH) antagonist degarelix (brand name: FIR
25 per page50 per page75 per page100 per page